Pediatric Diabetes Consortium (PDC)

The Pediatric Diabetes Consortium (PDC), founded in 2009, is a network dedicated to improving the care of children with type 1 diabetes. Its goal is to create a large treatment outcome registry whose assessment will give insight into which treatment regimens are most successful. The consortium will first focus on the treatments given to newly diagnosed children as research suggests that initial therapy can be critical to a child’s long-term health.

The consortium, consists of six clinical centers:
    Baylor College of Medicine (PI Morey Haymond, M.D.),
    Stanford (PI Bruce Buckingham, M.D.),
    Children's Hospital, LA (PI Jamie R. Wood, M.D.),
    University of Colorado, Denver (PI Georgeanna J. Klingensmith, M.D.),
    University of Florida (PIs Desmond Schatz, M.D. and Janet Silverstein, M.D.),
    Yale University (PIs Eda Cengiz, M.D. and William Tamborlane, M.D.),

and a coordinating center: Jaeb Center for Health Research (Executive Director Roy Beck, M.D., Ph.D.).

Dr. Tamborlane of Yale Pediatric Endocrinology serves as the PDC chair and Dr. Kingensmith of the Barbara Davis Center for Childhood Diabetes, University of Colorado, Denver serves as the PDC vice-chair.

For more information about the PDC see PDC Organizational Structure and Policies.